Cubist To Present At August Investor Conference
Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that company management will discuss Cubist’s business activities and financial outlook at investor conferences during August 2012.
- On Wednesday, August 1, David McGirr, SVP and CFO; Greg Stea, SVP Commercial Operations; and Michael Tomsicek, SVP and Deputy CFO will host one-on-one meetings at the Goldman Sachs Small Caps One-on-One Summit at the Ritz-Carlton Hotel in Chicago. Eileen C. McIntyre, Senior Director, Investor Relations will be joining as well. These meetings will not be webcast.
- On Thursday, August 9, Steven Gilman, EVP and CSO, will host one-on-one meetings at the UBS Biotech Summer 1x1 Conference in San Francisco. Mr. Gilman will be joined by Eileen C. McIntyre, Senior Director, Investor Relations. These meetings will not be webcast.
- On Wednesday, August 15, Michael Bonney, CEO, will present at 10:55 a.m. ET at the Wedbush Securities 2012 Life Sciences Management Access Conference at the Le Parker Meridien in New York. The presentation will be accessible live through Cubist’s website at www.cubist.com in the Investor Relations Conference Calendar section and will remain available there for a period of 30 days after the presentation.
About Cubist
Cubist Pharmaceuticals, Inc. is a biopharmaceutical company focused on
the research, development, and commercialization of pharmaceutical
products that address significant unmet medical needs in the acute care
environment. Cubist is headquartered in Lexington, Mass. Additional
information can be found at Cubist’s
website.
Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Dividend Stock Advisor
TRY IT FREENew! $49.95/yr
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Real Money
TRY IT FREE24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
Product Features:
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
